ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $349,000 | +44.8% | 2,029 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $241,000 | -71.8% | 1,924 | -69.5% | 0.00% | -75.0% |
| Q1 2021 | $854,000 | +3.8% | 6,299 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $823,000 | +13.7% | 6,431 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $724,000 | +17.3% | 6,431 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $617,000 | +52.3% | 6,479 | +43.8% | 0.00% | +33.3% |
| Q1 2020 | $405,000 | +84.1% | 4,506 | -46.0% | 0.00% | -50.0% |
| Q1 2016 | $220,000 | -41.2% | 8,350 | +8.8% | 0.01% | -40.0% |
| Q4 2015 | $374,000 | +47.8% | 7,673 | -24.4% | 0.01% | +42.9% |
| Q3 2015 | $253,000 | -99.9% | 10,150 | +13.4% | 0.01% | +16.7% |
| Q2 2015 | $283,178,000 | +110950.2% | 8,950 | +33.5% | 0.01% | +20.0% |
| Q1 2015 | $255,000 | – | 6,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |